期刊文献+

胶质瘤术后癫痫发生影响因素分析 被引量:3

Predisposing factors for postoperative epilepsy in patients with gliomas
暂未订购
导出
摘要 目的探讨胶质瘤术后癫痫发生的影响因素。方法回顾性分析接受开颅手术且资料完整胶质瘤病例258例,以性别、年龄、主要症状、阳性体征、术前癫痫病史、癫痫时间、病变部位、手术入路、皮质牵拉伤、动静脉损伤、肿瘤切除程度、术后水肿、病理性质、病变复发、手术次数、放射治疗等16项可能的影响因素为自变量,设定术后"发生癫痫"为因变量,使用logistic回归分析研究相关的影响因素。结果术前癫痫史、手术入路、术后水肿、病理性质、病变复发等5个因素为胶质瘤术后癫痫发生的影响因素。结论胶质瘤术后癫痫的发生影响病人生活质量,针对癫痫发生影响因素的防治,有望减少胶质瘤术后癫痫发生。 Objective To explore the predisposing factors for postoperative epilepsy in patients with gliomas. Methods A total of 258 glioma patients with complete clinical data receiving cranial surgeries were analyzed retrospectively. With gender, age, predominant symptoms, positive signs, history of preoperative epilepsy, time of epilepsy onset, tumor location, surgical approaches, cortical injury, arterial and venous injury, scope of tumor resection, postoperative edema, tumor pathology, tumor recurrence, number of operation, radiation therapy as the independent variables, the occurrence of postoperative epilepsy was analyzed as the dependent variable using logistic regression to identify the risk factors for postoperative epilepsy. Results History of preoperative epilepsy, surgical approaches, postoperative edema, tumor pathology and tumor recurrence were identified as the risk factors for postoperative epilepsy in glioma patients. Conclusion Postoperative epilepsy severely affected the quality of life ofglioma patients, and rigorous treatment targeting the risk factors may decrease the occurrence of postoperative epilepsy.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第12期2233-2234,2238,共3页 Journal of Southern Medical University
关键词 胶质瘤 癫痫 影响因素 glioma epilepsy related factors
  • 相关文献

参考文献8

  • 1Pittasch D, Johannes C. Diagnostic value of epileptic seizures in cerebral gliomas [ J ]. Zentralbl Neurochir, 1985, 46(4): 344-7.
  • 2Riva M, Salmaggi A, Marchioni E, et al. Tumour-associated epilepsy: clinical impact and the role of referring eentres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group[J]. Ncurol Sci, 2006, 27(5): 345-51.
  • 3Hwang SL, Lieu AS, Kuo TH, et al. Preoperative and postoperative seizures in patients with astrocytic tumors: analysis of incidence and influencing factors[ J ]. J Clin Neurosci, 2001, 8(5): 426-9.
  • 4Iannelli A, Guzzatta F, Battaglia D. Surgical treatment of treatment of temporal tumors associated with epilepsy in children [ J ]. Pediatr Neurosurg, 2000, 32(5): 248-54.
  • 5Tandon PN, Mahspatra AK, Khosla A, et al. Epileptic seizures in supratentorial gliomas[J]. Neurl India, 2001, 49(1): 55-9.
  • 6Roger J, Packer, MD, Leslie N, et al. Seizure control following tumor surgery for childhood cortical low-grade gliomas[J].J Neurosurg, 1994, 80: 998-1003.
  • 7Telfeian AE, Philips MF, Crino PB. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma mulforme[J]. J Exp Clin Cancer Res, 2001, 2(1): 5-10.
  • 8Krzyszkowski T, Czepke R, Betlej M. Prognostic value of epileptic seizures in patients with cerebral gliomas [J ]. Ann Acad Med Stetin, 2004, 50(1): 35-40.

同被引文献30

  • 1孙彦辉,陈新忠,白芹.术中癫痫诱发试验联合皮层热灼治疗胶质瘤所致癫痫的临床研究[J].国际神经病学神经外科学杂志,2007,34(3):208-211. 被引量:9
  • 2谢泽宇,庄明华,丁山,骆健明,许宏武,李永生,孙德麟.幕上胶质瘤及脑膜瘤并癫痫原因分析及综合抗痫治疗[J].南方医科大学学报,2007,27(7):1119-1121. 被引量:8
  • 3郭熙雄,陈谦学,田道锋,吴立权,陈伟.脑胶质瘤致癫痫因素临床分析[J].中国临床神经外科杂志,2007,12(9):531-532. 被引量:22
  • 4Buckingham SC,Campbell SL, Hass BR, et al. Glutamate release by primary brain tumors induces epileptic activity [J]. Nature Medicine,2011,17(10) :1269 1274.
  • 5Espie CA, Watkins J, Duncan R, et al. Perspectives on epi- lepsy in People with intellectual disabilities:comparison of family caret,staff carer and clinician score profiles on the Glasgow Epilepsy Outcome Scale (GEOS) [J]. Seizure, 2003,12(4) :195-202.
  • 6Schaller B. Influences of brain tumor-associated pH chan- ges and hypoxia on epileptogenesis [J]. Acta Neurol Scand, 2005,111 (2) : 75-83.
  • 7Wolf HK, Roos D, Blumcke I, et al. Perilesional neuro- chemical changes in focal epilepsies [J]. Acta Neuro- pathol, 1996,91 (4) : 376-384.
  • 8Guan J, Lo M,Dockery P, et al. The xc-cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine[J]. CancerChemother Pharmacol, 2009,64(3) : 463-472.
  • 9Timmerman LA, Holton T, Yuneva M, et al. Glutamine sensitivity analysis identifies the xCT antiporter as a corn mon triple-negative breast tumor therapeutic target [J]. Cancer Ce11,2013,24(4) :450-465.
  • 10Berntsson SG, Maimer B,Boncty ML, et al. Tumor-associ- ated epilepsy and glioma:are there common genetic path ways? [J].ActaOncol,2009,48(7):955 963.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部